This Article Full Text Full Text (PDF) All Versions of this Article: 116/22/2571    most recent CIRCULATIONAHA.107.706515v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perrino, C. Articles by Naga Prasad, S. V. Search for Related Content PubMed PubMed Citation Articles by Perrino, C. Articles by Naga Prasad, S. V. Related Collections Cell signalling/signal transduction Heart failure - basic studies

(Circulation. 2007;116:2571-2579.)
© 2007 American Heart Association, Inc.

Heart Failure

Dynamic Regulation of Phosphoinositide 3-Kinase- Activity and β-Adrenergic Receptor Trafficking in End-Stage Human Heart Failure

Cinzia Perrino, MD, PhD; Jacob N. Schroder, MD; Brian Lima, MD; Nestor Villamizar, MD; Jeffrey J. Nienaber, MD; Carmelo A. Milano, MD; Sathyamangla V. Naga Prasad, PhD

From the Department of Medicine (C.P.) and Department of Surgery (J.N.S., B.L., N.V., J.J.N., C.A.M.), Duke University Medical Center, Durham, NC, and Department of Molecular Cardiology (S.V.N.P.), Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio. Dr Perrino is currently at the Division of Cardiology, Federico II University, Naples, Italy.

Correspondence to Sathyamangla V. Naga Prasad, PhD, NB50, Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195. E-mail prasads2{at}ccf.org

Received April 1, 2007; accepted September 21, 2007.

Background— Downregulation of β-adrenergic receptors (βARs) under conditions of heart failure requires receptor targeting of phosphoinositide 3-kinase (PI3K)– and redistribution of βARs into endosomal compartments. Because support with a left ventricular assist device (LVAD) results in significant improvement of cardiac function in humans, we investigated the effects of mechanical unloading on regulation of PI3K activity and intracellular distribution of βARs. Additionally, we tested whether displacement of PI3K from activated βARs would restore agonist responsiveness in failing human cardiomyocytes.

Methods and Results— To test the role of PI3K on βAR endocytosis in failing human hearts, we assayed for PI3K activity in human left ventricular samples before and after mechanical unloading (LVAD). Before LVAD, failing human hearts displayed a marked increase in βAR kinase 1 (βARK1)–associated PI3K activity that was attributed exclusively to enhanced activity of the PI3K isoform. Increased βARK1-coupled PI3K activity in the failing hearts was associated with downregulation of βARs from the plasma membrane and enhanced sequestration into early and late endosomes compared with unmatched nonfailing controls. Importantly, LVAD support reversed PI3K activation, normalized the levels of agonist-responsive βARs at the plasma membrane, and depleted the βARs from the endosomal compartments without changing the total number of receptors (sum of plasma membrane and early and late endosome receptors). To test whether the competitive displacement of PI3K from the βAR complex restored receptor responsiveness, we overexpressed the phosphoinositide kinase domain of PI3K (which disrupts βARK1/PI3K interaction) in primary cultures of failing human cardiomyocytes. Adenoviral-mediated phosphoinositide kinase overexpression significantly increased basal contractility and rapidly reconstituted responsiveness to β-agonist.

Conclusions— These results suggest a novel paradigm in which human βARs undergo a process of intracellular sequestration that is dynamically reversed after LVAD support. Importantly, mechanical unloading leads to complete reversal in PI3K and βARK1-associated PI3K activation. Furthermore, displacement of active PI3K from βARK1 restores βAR responsiveness in failing myocytes.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				S. V. Naga Prasad, Z.-H. Duan, M. K. Gupta, V. S. K. Surampudi, S. Volinia, G. A. Calin, C.-G. Liu, A. Kotwal, C. S. Moravec, R. C. Starling, et al. Unique MicroRNA Profile in End-stage Heart Failure Indicates Alterations in Specific Cardiovascular Signaling Networks J. Biol. Chem., October 2, 2009; 284(40): 27487 - 27499. [Abstract] [Full Text] [PDF]